Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 August 2022 | Story Anthony Mthembu | Photo Supplied
Day-residence representatives hard at work during the outreach programme aimed at attracting off-campus students to join any of the several day residences.

The impact of COVID-19 on students who started their studies at the UFS in 2020 and 2021, is the fact that they had to experience the UFS student life virtually. As such, the ability to experience day-residence culture was minimal.
Consequently, the SRC: Day Residences, Nontando Kalipa, along with representatives from the seven day residences and the SRC, visited off-campus accommodation as a means to market day residences. The initiative ran from 1 to 4 August 2022. “We went to various communes and other student accommodation such as Quattro, CampusKey, and ResPublica, and explained our mandate as SRC: Day Residences to the off-campus students,” Kalipa expressed.

The Importance of the Initiative

According to Kalipa, there is a lack of knowledge about the role and relevance of day residences in student life; this was seen in the responses received from some of the off-campus students who were approached during the outreach. “We came across some students who had never heard of day residences, and others who knew of them but didn’t really understand their function,” stated Kalipa. Therefore, she insisted that representatives from the respective day residences should also be involved in the initiative. “The RC primes were there specifically to share their experiences about day residences with off-campus students,” said Kalipa.

The Relevance of Day Residences in Student Life

“Day residences offer a holistic student experience, so off-campus students can expect any of the seven day residences to assist them in becoming well-rounded individuals,” expressed Corbin Butler, the incoming SRC for Day Residences. These spaces offer off-campus students access to cultural and sporting activities, such as Stagedoor, SingOff, and basketball tournaments, among others. On-campus students have the advantage of being exposed to other students from all walks of life and interacting with them consistently. As such, Butler maintains that day residences aim to bridge the existing gap by creating that very same experience for off-campus students. “We don’t want you to just get a degree and leave, we also want to capacitate you with life skills, and that’s the benefit of being part of a day residence,” Butler stated.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept